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Abstract
Background: Allograft vasculopathy (AV) and native atherosclerosis (NA) share the presence of a T-cell mediated
inflammatory response, but differ in overall plaque morphology and growth rate. We studied the distribution and frequency
of regulatory- and cytotoxic T cells in the arterial intima lesions in both conditions.
Methodology/Principal Findings: The study is based on vessels of 15 explanted human renal allografts with AV and 10
carotid artery plaques obtained at surgery. Distribution and frequency of cytotoxic- and regulatory T cells, as identified by
the expression of Granzyme B (GrB) and FOXP3 was established in NA and AV. Furthermore, we compared the distribution
of these cells in AV with the perivascular, interstitial renal tissue using immunohistochemistry. The total number of T cells
was much higher in AV than in NA lesions (7116135 and 3768 CD3/mm
2 respectively, p,0.005, mean, 6 SEM). Total
numbers of FOXP3
+ regulatory cells were also significantly increased in AV (36610 and 0.960.3 FOXP3
+/mm
2 p,0.05), but
relative numbers, expressed as a percentage of the total number of CD3
+ T cells ((FOXP3
+/CD3
+) 6100), were not
significantly different (4.6%60.9 and 2.7%60.6). GrB
+ cells were rare in NA, but significantly increased numbers of GrB
+ cells
were found in AV lesions (85624 and 0.260.1 GrB
+/mm
2,p ,0.05). Perivascular tissues in the allografts showed a higher
relative frequency of FOXP3
+ cells than adjacent intimal lesions (14.0%62.7 and 4.6%60.9, respectively, p,0.05), but a
lower frequency of GrB
+ cytotoxic T cells (16.1%62.7 and 22.6%63.6, p,0.05).
Conclusions: Similar to NA, AV is characterized by a low frequency of intimal FOXP3
+ regulatory T cells. Moreover, significant
spatial differences exist in the distribution of functional T cell subsets between the intra- and extravascular micro-
environments of the graft.
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Introduction
Allograft vasculopathy (AV) is a hallmark of chronic allograft
dysfunction in heart and kidney transplantation [1,2]. AV differs
from naturally occurring plaques in native arteries (native
atherosclerosis, NA) by its rapid onset and progression, and
distinct morphologic features like concentric rather than eccentric
distribution of plaques in the affected vessels [3]. While NA is
basically a lipid related chronic inflammatory process in the vessel
wall, AV is generally considered to be an alloimmune process.
T cells play an important role in the pathogenesis of both NA
and AV. By the secretion of inflammatory mediators and direct
cell-cell interactions with other plaque cells, activated T cells are
able to induce the proliferation or apoptosis of intimal cells,
modulate the synthesis of extracellular matrix components and
thus directly influence atherosclerotic plaque growth and stability
[4]. In NA, Th1 cells, secreting high levels of interferon (IFN)-c,
are considered to be the most important T cell subset contributing
to atherogenesis [4]. Th1 cells also participate in the pathogenesis
of AV, but in addition, there is evidence for cytotoxic responses as
well, based on the presence of Perforin and Granzyme B (GrB)
positive T-cells in arteries of transplanted hearts and kidneys [5,6].
Regulatory T cells (Treg), including the CD4
+CD25
high-
FOXPP3
+ subset (‘natural occurring Treg’) play a central role in
inducing and maintaining immunologic tolerance and the
termination of immune responses [7]. In experimental transplan-
tation it has been shown that FOXP3
+ regulatory T cells play an
important role preventing graft loss and inducing tolerance, and
may prevent AV [8] but their significance in human transplan-
tation is still a matter of debate [9].
It has been proposed that the intima of arteries represents a
specialized immunological microenvironment due to the presence
of specific immunocompetent cells (e.g. endothelial cells, macro-
phages/foam cells, T-cells, mast cells) and the typical distribution
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that one and the same initiating inflammatory factor may lead to
different types of immune responses in the intima, compared to the
extravascular tissue. The presence of GrB
+ cytotoxic T cells and
FOXP3
+ regulatory T cells has been studied in heart and kidney
allografts [6,11,12], but there are no studies that systematically
compared the presence of these cells in the intima of arteries and
the adjacent perivascular tissue. In this manuscript we report our
quantitative immunohistochemical analysis of the in situ presence
and distribution of FOXP3
+ T cells and GrB
+ cytotoxic T cells in
NA and in AV.
Methods
Ethics Statement
The medical ethical review board granted a waiver for informed
consent because only leftover tissue of normal clinical procedures,
no longer required for diagnosis or clinical management was used
in this study. All acquired data were analyzed anonymously. Ethics
approval was obtained from the Medical Ethical Review Board of
the Academic Medical Centre, University of Amsterdam.
Specimens
This study is based on 25 paraffin embedded tissue blocks of 15
patients that underwent nephrectomy for renal failure due to
chronic allograft dysfunction. Tissue blocks were retrospectively
retrieved from the archives of the Pathology Department of the
Academic Medical Centre. Details of the patients are summarized
in Table 1. H&E and PASD stainings were prepared for
histopathological grading of plaque constituents, parameters of
allograft vasculopathy and histological diagnoses according to the
latest Banff update ’07 [13]. Small- and medium sized renal
arteries (interlobar-, arcuate and interlobular arteries) were
screened histomorphologically for concentric or eccentric distri-
bution of intimal lesions and for the presence of the following
plaque components: cellular intimal hyperplasia, sclerosing
fibrosis, lipid core and inflammatory cells. As reference materials
we sampled native atherosclerotic plaques from carotid endarter-
ectomy specimens of 10 patients operated for symptomatic carotid
artery disease (see table 1). NA specimens were handled following
the same procedures as for AV lesions. All plaques were advanced,
lipid/fibrolipid plaques (type IV, Va and Vb, according to the
classification of the American Heart Association [14]. Plaques
displaying major thrombotic events were not encountered in this
series. We used carotid artery plaques since surgical materials of
renal arteries with significant atherosclerosis were not available.
Immunohistochemistry
Immunohistochemical double stainings were performed on
5 mm thick, serial sections of all the tissue blocks. For
immunohistochemical analysis, the following antibodies were
used: rabbit monoclonal anti-CD3 (Pan-T, clone SP7, Thermo
Scientific/LabVision, Fremont, CA, USA); rabbit monoclonal
anti-CD8 (Cytotoxic T cells, clone SP16, Thermo Scientific/
LabVision); mouse monoclonal anti-FOXP3 (Treg, clone 236A/
E7; Abcam, Cambridge, UK); mouse monoclonal anti-Granzyme
B (clone GRB-7, Monosan, Sanbio, Uden, the Netherlands [15]);
mouse monoclonal anti-CD57 (NK cells, clone HNK-1, Thermo
Scientific/LabVision); mouse monoclonal anti-CD68 (macrophag-
es, PG-M1, Dako, Glostrup, Denmark); alkaline phosphatase (AP)-
conjugated mouse anti-tryptase (Chemicon/Millipore, Temecula,
CA, USA); rabbit polyclonal anti C4d (Biomedica Medizinpro-
ducte, Vienna, Austria) and mouse monoclonal anti- polyoma
(BK) virus (clone DP02, Calbiochem/Oncogene Research Products,
Cambridge, MA, USA). As secondary step (except for the tryptase
staining, which antibody was already AP labelled) we used alkaline
phosphatase conjugated anti rabbit- and anti mouse-polymers
(Immunologic, Duiven the Netherlands). Immunohistochemical
sequential double alkaline phosphatase staining was performed as
previously described [16]. Negative control experiments were
performed with matched species or mouse isotype control reagents
using similar immunoglobulin concentrations.
Quantification
Digital images covering the complete pathological intima were
obtained from the histological specimens using a Leica DFC500
digital camera mounted on a Leica DM5000B microscope. T cells
subsets (CD3
+/FOXP3
2, CD3
+/FOXP3
+, CD8
+Granzyme B
2,
CD8
+/GrB
+) were counted in the intima of NA and AV specimens
with Image Pro Plus image analysis software (Media Cybernatics,
Bethesda MD, USA) using the ‘manual tag’ option. Image Pro
Plus was also used for measuring the total intimal surface area of
the NA and AV specimens. Only the surface area of fibrous tissue
was measured (the area occupied by atheroma was not included).
Furthermore, in the nephrectomy specimens 3 microscope fields of
‘inflammatory hotspots’ (areas with high density of infiltrates at
scanning magnification, 206objective) were selected in the direct
peri-adventitial area of the vessels, and the numbers of T cell
subsets were counted in these areas also. Of each tissue block, the
total number of CD3
+ T cells that were counted to determine the
frequency of a specific T cell subset was in the range of 300–2500.
The numbers of cells were expressed as mean number of cells/
mm
2 6 SEM. GrB
+ and FOXP3
+ cells were also expressed as a
percentage of the total number of CD8
+ or CD3
+ cells,
respectively.
Statistical Analysis
Statistical differences between NA and AV were calculated
using two tailed unpaired t-test. Differences between intra and
extravascular T cells subsets in the nephrectomy specimens were
analyzed using a two tailed paired t-test. Values of p,0.05 were
considered statistically significant. Statistical analysis was per-
formed using GraphPad Prism version 4.0 (GraphPad Software
Inc, LaJolla, CA, USA).
Results
1. Histopathological findings
All NAs lesions contained a lipid core albeit with considerable
variation in volume, surrounded by collagen and other extracel-
lular matrix components as well as smooth muscle cells (SMC) and
variable degrees of inflammatory infiltrates composed of macro-
phages, foam cells and T lymphocytes.
The characteristics of the nephrectomy patients are summarized
in table 1, and representative histological- and immunohistochem-
ical stainings are illustrated in figure 1. All patients showed chronic
allograft vasculopathy superimposed to acute rejection (for Banff
classification see table 1). None of the nephrectomies had signs of
polyoma virus infections (data not shown). Interlobar arteries and
small parenchymatous arteries showed concentric intimal lesions
composed of SMC cells and prominent mononuclear inflamma-
tory infiltrates, mainly macrophages and T lymphocytes. The vast
majority of arteries also contained CD68
+ foam cells and
multifocal extracellular lipid deposits. Inflammatory cells were
frequently found in close proximity of the endothelial lining of the
vessels and in many cases ‘‘lifting up’’ of the endothelial layer
(endothelialitis) was observed. Renal veins showed similar
Treg and Tcyt in AV
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shown).
2. T cells and T cell-subsets in native atherosclerosis and
transplantation arteriosclerosis
Numbers of T cells in NA and AV were assessed with the pan T
cell marker CD3. The overall density of T cells in AV appeared
significantly higher than in NA lesions (7116135 vs. 36.868.3
CD3
+T cells/mm
2, respectively, mean 6 SEM, see figure 2A).
Similarly, the numbers of CD8
+cells/mm
2 were also significantly
higher in AV compared to NA (370677 vs.15.362.7, respectively,
see figure 2B).
FOXP3
+ T cells were relatively rare in NA specimens, but
significantly higher numbers were encountered in all AV
specimens (0.960.3 vs. 36.2610.1 FOXP3
+/mm
2, see figure 1B–
D, and 2C). However, when the frequency of FOXP3
+ Treg was
expressed as a percentage of the total numbers of CD3
+ cells that
were present in the diseased intima, it appeared that the frequency
of FOXP3
+ T cells in AV were slightly (but not statistically
significant) higher compared to NA (2.7%60.6 and 4.6%60.9,
respectively, figure 2E).
Cytotoxic, GrB
+ T cells were rare in native atherosclerotic
plaques (0.260.1 cells/mm
2). In 6/10 of the studied samples no
GrB
+ cells were encountered, while in the samples that did contain
GrB
+ cells their numbers were always very low (,5 cells per
section). In sharp contrast, significantly increased numbers of
GrB
+ cells were encountered in all AV affected arteries (85624
cells/mm
2, see fig. 2D, and a representative histological examples
in figure 1E and F ). In addition, when expressed as a percentage
of the total number of CD8 positive cells present in the
pathological intima, the numbers of GrB
+ cells were significantly
higher in AV when compared to NA (figure 2F)
Although virtually all GrB
+ cells co-expressed CD8, sparse
CD8
2GrB
+ cells were observed in renal allograft specimens. Most
of these cells were not encountered in the affected vessels, but in
the renal interstitial tissue. Immunohistochemical double staining
with anti CD57 identified these cells as NK cells (see fig. 3A). GrB
+
mast cells and/or macrophages as has been described by others,
were not encountered (see figure 3B).
Table 1. Demographical and histopathological characteristics of the patients and nephrectomy specimens.
A: Patients / carotid enarterectomies
ID Sex Age (years) AHA classification
1 m 47 AHA Vb
2 m 65 AHA Vb
3 m 64 AHA Va
4 m 64 AHA Va
5 m 73 AHA Va
6 f 68 AHA Va
7 m 72 AHA Va
8 f 73 AHA IV
9 m 86 AHA IV
10 m 62 AHA IV
B: Patients / renal allografts
Id Sex Age (years) Graft survival (years) Bannf classification
1 f 41 2.2 ACR IIA
2 f 41 0.7 ACR III+AHR III
3 m 30 10.3 *
4 m 44 8.7 ACR IIA+AHR II
5 m 43 0.3 ACR III**
6 m 54 0.3 ACRIIb+AHR II
7 m 15 8.5 ACRIIb+AHR II
8 m 33 17.7 ACR IIb+AHR II
9 m 35 1.0 ACR III+AHR III
10 m 29 7.8 ACR IIb+AHR II
11 f 58 14.2 ACR In+AHR II
12 m 54 1.6 ACR III+AHR III
13 f 39 2.5 ACR II+AHR II
14 m 49 0.5 ACR II+AHR II
15 f 60 0.3 ACR III
*not interpretable: no renal cortex present in the available tissue blocks to determine Banff score;
**: C4d not interpretable because of extensive haemorrhage.
doi:10.1371/journal.pone.0018656.t001
Treg and Tcyt in AV
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Finally, we also compared the intra- and extra vascular
percentages of FOXP3
+ T cells and activated cytotoxic (GrB
+)T
cells in the tissue specimens with AV. The frequency of FOXP3
+
cells, that were found in relative low numbers in the intima of
vessels with AV (4.6%60.9 ), was significantly increased in the
peri-adventitial tissue of the renal allograft specimens (14.6%62.0,
p,0.05, see figure 4A). In contrast, the frequency of GrB
+ T cells
was significantly lower in the peri-adventitial tissue (14.6%62.0)
when compared to the intima in AV(22.663.6, p,0.05, figure 4B).
Discussion
In this study we investigated the presence and distribution of
FOXP3
+ regulatory- and GrB
+ cytotoxic T cells in native and
transplant arteriosclerosis, and compared the intra- and extra
vascular distribution of FOXP3
+ and GrB
+ in renal allograft
explants for chronic rejection.
Quantitative analysis of T cells revealed that the density (cells/
mm
2) of CD3
+ and CD8
+ T cells in the intima are more than 100-
fold higher in AV compared to NA. In native atherosclerotic
plaques T cells are not equally distributed throughout the intima.
Local ‘hotspots’ T cells can frequently be found in ‘shoulder’ of the
plaque, near the atheroma, and in the fibrous cap, and outside
these areas T cells are usually sparsely present. T cells in these
hotspots are considered very important because activated T cells
contribute to plaque destabilization and rupture, typically on these
locations [4,17]. In AV on the other hand, T cells are more evenly
distributed throughout the intima, and not as ‘hotspots’, as seen in
NA. We hypothesise that due to this diffuse localisation of T cells
in AV, these cells contribute to the accelerated and concentric
growth pattern as seen in AV.
FOXP3
+ T cells were more frequently encountered in AV when
compared to NA, where these cells were relatively rare. However,
also in AV relative numbers of FOXP3
+ cells were low when
expressed as a percentage of the total number of T cells.
Hagemeijer et al recently studied FOXP3
+ regulatory T cells in
Figure 1. Histological examples of regulatory- and cytotoxic T cells in a nephrectomy specimen with allograft vasculopathy. All
pictures are from the same specimen. A: H&E, overview. Bar=100 mm. B: Same area as in A, doublestained with FOXP3 (red) and CD3 (blue).
Bar=100 mm. C: Detail from B, extra vascular area. Bar=25 mm. Note the nuclear staining of FOXP3. D. Detail of B, intravascular area (intima).
Bar=25 mm. E: extra-vascular area (same region as in C), CD8 (blue)/Granzyme B(red) double staining. Bar=25 mm. F: intima (same region as D), CD8
(blue)/Granzyme B(red) double staining,. Bar=25 mm. Inset shows high power magnification, showing intracellular GranzymeB
+ granules (red).
doi:10.1371/journal.pone.0018656.g001
Treg and Tcyt in AV
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+ T cells (A), CD8
+ T cells (B), FOXP3
+ T cells (C and E) and Granzyme B
+ T cells (D and
F) in the intima of native atherosclerotic plaques (NA) and the intima of vessels with allograft vasculopathy (AV). *: P,0.05,
** P,0.005.
doi:10.1371/journal.pone.0018656.g002
Figure 3. A: Immunohistochemical doublestaining of a renal allograft specimen with Granzyme B (red) and CD57 (blue), illustrating
a Granzyme B positive NK cell. Bar=10 mm. B: Doublestaining of Granzyme B (red) with CD68 (blue). Note that macrophages do not express
Granzyme B. Bar=25 mm.
doi:10.1371/journal.pone.0018656.g003
Treg and Tcyt in AV
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observe any FOXP3
+ Tregs in cardiac AV. Our present results,
obtained in the kidney are therefore, to some extent, in variance
with his results because we did encounter these cells in specimens
with AV. Still, both studies clearly show that the numbers of
FOXP3
+ T cells are low in AV, which especially becomes clear
when the frequency of these cells is expressed as a percentage of
the total number of T cells present in the plaques.
We have previously reported on the presence of FOXP3
+ T
cells in native atherosclerosis, and observed that the numbers of
Treg in native atherosclerosis, when expressed as a percentage of
the total number of CD3
+ T cells, were significantly lower when
compared to normal skin and inflammatory dermatoses (psoriasis,
spongiotic dermatitis, lichen planus and Leishmaniasis) [18,19]. In
normal as well as in inflammatory skin we found the frequency of
Treg to be in the range of 15–25%, whereas in native
atherosclerotic plaques their frequency was in the range of 1–
5%, depending of the type of lesion. In the present study we found
that the frequency of FOXP3
+ cells in AV as low, and in the same
range as observed in native atherosclerosis. Moreover, the
frequency of FOXP3
+ cells outside the affected arteries was
significantly higher, in levels almost comparable to those
previously observed in normal skin as well as chronic inflamma-
tory skin diseases [18]. It thus appears that low frequency of
FOXP3
+ cells is also a characteristic feature for AV.
In an experimental model of atherosclerosis, Mor at al. have
shown that oxidized lipids inhibit FOXP3 expression and
attenuate suppressive properties of Treg [20]. Based on these
findings, we hypothesized that the low frequency of Treg, as
observed in native atherosclerosis was a consequence of the
presence of oxidized lipids in the lesions [19]. AV lesions may also
contain lipids, as macrophage foam cells are frequently encoun-
tered in this type of lesions. Therefore, the decreased frequency of
Treg in AV could also be the result of lipids, that are usually
present in the intima. This hypothesis is substantiated by our
present observation that outside the arteries, in the interstitial renal
parenchyma, the frequency of FOXP3
+ Treg are significantly
higher. Finally, further indirect support for this hypothesis is also
provided by the observation that hypercholesterolemia is an
independent risk factor for AV [21].
GrB staining of CTL indicates activation of an important
mechanism of cell mediated cytotoxicity carried out by lytic
proteins that are present in the cytoplasmic cytotoxic granules of
cells [15]. Besides cytotoxic effects on target cells, Granzymes may
also contribute to remodelling and weakening of the intimal
extracellular matrix, by degrading extracellular matrix proteins
such as proteoglycans [22]. In NA, GrB
+ lymphocytes were very
rare, implying that in this type of lesions these cells do not play a
role in plaque remodelling or T-cell mediated cytotoxicity. In
contrast, large numbers of GrB
+ T cells were present in arteries of
the renal explants, showing that cytotoxic T cells responses play an
important role in the pathogenesis of AV.
An interesting finding of this study was that the frequency of
intravascular, activated cytotoxic CD8
+ lymphocytes was signifi-
cantly higher compared to the extra-vascular compartment. We
hypothesize that the increased numbers of intravascular GrB
+ cells
in AV is a consequence of the relative low frequency of FOXP3
+
cells.
Our present findings are, to some extent, in contrast with a
study by Choy et al, who also studied GrB expression in native
atherosclerosis and transplant vascular disease [23]. In that study
the authors showed extensive diffuse intracellular staining with
GrB in macrophages, SMC (also in the media) and leukocytes in
specimens with advanced native atherosclerosis and transplant
arteriosclerosis. In this study, cytotoxic T cells were very rare in
native atherosclerotic specimens, which is also in agreement with
results already reported by others [24]. Moreover, we always
observed GrB as clear intracellular granules in conjunction with
CD8
+, and occasionally also with CD57
+ cells (figure 3). This
staining pattern is exactly what one could expect, since granzymes
are know to be present and stored in such cytotoxic granules. The
most plausible explanation for the observed difference between
our study and that of Choy is the primary antibody used. Choy
and colleagues used an antibody for Santa Cruz, while we used the
well characterized and frequently used GRB7 clone. Although it is
known that activated mast cells are able to express GrB [25], we
did not observe tryptase
+GrB
+ cells in any of the sections, which
suggests that activated mast cells do not play an important role in
AV.
Patients’ immunosuppressive therapy was withdrawn (in our
study group at least 2 weeks for all patients) before the surgical
removal of dysfunctional allografts. Indeed, besides AV, we also
observed several signs of acute rejection in these specimens. It has
been shown that infiltration with GrB
+ [25] and FOXP3
+ [26]
Figure 4. Differences between intra- and extravascular functional T cells subsets in renal allograft vasculopathy. A: numbers of
FOXP3
+ T cells, expressed as a percentage of the total number of CD3
+ T cells. B: numbers of GrB
+ T cells, expressed as a percentage of the total
number of CD8
+ cells. *: p,0.05, paired T test.
doi:10.1371/journal.pone.0018656.g004
Treg and Tcyt in AV
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likely that the presence of a part of these cells we observed in the
allografts were the result of such a response. This could also have
contributed to the observed difference in absolute numbers of
functional T cell subsets between NA and AV specimens.
However, this also implicates that our present finding were not,
or at least to lesser extent, biased by the immunosuppressive
therapy.
In conclusion, in this study we have shown that the distribution
of functional T cell subsets differs between the intra- and
extravascular compartment in renal allografts with chronic
allograft dysfunction. The relative low numbers of FOXP3
+ cells,
and relatively high numbers of cytotoxic cells suggest that
impaired T cell suppression in the arterial intima contribute to
chronic allograft vasculopathy. Therapeutic enrichment of intra-
vascular regulatory T cells, as has been proposed for the treatment
of native atherosclerosis [27], may also be an interesting novel
strategy to prevent chronic allograft vasculopathy.
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